Potential disease-modifying therapies for Huntington's disease: lessons learned and future opportunities
出版年份 2022 全文链接
标题
Potential disease-modifying therapies for Huntington's disease: lessons learned and future opportunities
作者
关键词
-
出版物
LANCET NEUROLOGY
Volume 21, Issue 7, Pages 645-658
出版商
Elsevier BV
发表日期
2022-06-16
DOI
10.1016/s1474-4422(22)00121-1
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- An orally available, brain penetrant, small molecule lowers huntingtin levels by enhancing pseudoexon inclusion
- (2022) Caroline Gubser Keller et al. Nature Communications
- Safety and Feasibility of Research Lumbar Puncture in Huntington’s Disease: The HDClarity Cohort and Bioresource
- (2022) Filipe B. Rodrigues et al. Journal of Huntingtons Disease
- A biological classification of Huntington's disease: the Integrated Staging System
- (2022) Sarah J Tabrizi et al. LANCET NEUROLOGY
- Strategies for delivering therapeutics across the blood–brain barrier
- (2021) Georg C. Terstappen et al. NATURE REVIEWS DRUG DISCOVERY
- The use of wearable/portable digital sensors in Huntington's disease: A systematic review
- (2021) Rosanna Tortelli et al. PARKINSONISM & RELATED DISORDERS
- Double setback for ASO trials in Huntington disease
- (2021) Katie Kingwell NATURE REVIEWS DRUG DISCOVERY
- The Sigma-1 Receptor Mediates Pridopidine Rescue of Mitochondrial Function in Huntington Disease Models
- (2021) Luana Naia et al. Neurotherapeutics
- The coding and long noncoding single-cell atlas of the developing human fetal striatum
- (2021) Vittoria Dickinson Bocchi et al. SCIENCE
- Widespread and sustained target engagement in Huntington’s disease minipigs upon intrastriatal microRNA-based gene therapy
- (2021) Astrid Vallès et al. Science Translational Medicine
- Complications of intrathecal drug delivery therapy (ITDD): A retrospective study of 231 implantations between 1999 and 2014
- (2021) Erik Necking et al. CLINICAL NEUROLOGY AND NEUROSURGERY
- Approval of Aducanumab for Alzheimer Disease—the FDA’s Perspective
- (2021) Billy Dunn et al. JAMA Internal Medicine
- FAN1-MLH1 interaction affects repair of DNA interstrand cross-links and slipped-CAG/CTG repeats
- (2021) Antonio Porro et al. Science Advances
- Small molecule splicing modifiers with systemic HTT-lowering activity
- (2021) Anuradha Bhattacharyya et al. Nature Communications
- Volumetric MRI-Based Biomarkers in Huntington's Disease: An Evidentiary Review
- (2021) Kirsi M. Kinnunen et al. Frontiers in Neurology
- PET molecular imaging of phosphodiesterase 10A: An early biomarker of Huntington's disease progression
- (2020) Patrik Fazio et al. MOVEMENT DISORDERS
- Nusinersen in adults with 5q spinal muscular atrophy: a non-interventional, multicentre, observational cohort study
- (2020) Tim Hagenacker et al. LANCET NEUROLOGY
- Neuronal Replacement as a Tool for Basal Ganglia Circuitry Repair: 40 Years in Perspective
- (2020) Anders Björklund et al. Frontiers in Cellular Neuroscience
- Huntingtin-Lowering Therapies for Huntington Disease
- (2020) Blair R. Leavitt et al. JAMA Neurology
- Patterns of CAG repeat instability in the central nervous system and periphery in Huntington’s disease and in spinocerebellar ataxia type 1
- (2020) Ricardo Mouro Pinto et al. HUMAN MOLECULAR GENETICS
- Imaging Mutant Huntingtin Aggregates: Development of a Potential PET Ligand
- (2020) Longbin Liu et al. JOURNAL OF MEDICINAL CHEMISTRY
- Biological and clinical characteristics of gene carriers far from predicted onset in the Huntington's disease Young Adult Study (HD-YAS): a cross-sectional analysis
- (2020) Rachael I Scahill et al. LANCET NEUROLOGY
- Advancing gene therapies, methods, and technologies for Parkinson’s Disease and other neurological disorders
- (2020) Massimo S. Fiandaca et al. Neurologia i Neurochirurgia Polska
- Phase 1–2 Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS
- (2020) Timothy Miller et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sigma-1 and dopamine D2/D3 receptor occupancy of pridopidine in healthy volunteers and patients with Huntington disease: a [18F] fluspidine and [18F] fallypride PET study
- (2020) Igor D. Grachev et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Huntington disease: new insights into molecular pathogenesis and therapeutic opportunities
- (2020) Sarah J. Tabrizi et al. Nature Reviews Neurology
- Proenkephalin Decreases in Cerebrospinal Fluid with Symptom Progression of Huntington's Disease
- (2020) Valter Niemela et al. MOVEMENT DISORDERS
- Mutant huntingtin and neurofilament light have distinct longitudinal dynamics in Huntington’s disease
- (2020) Filipe B. Rodrigues et al. Science Translational Medicine
- The once and future gene therapy
- (2020) Karen Bulaklak et al. Nature Communications
- Analysis of mutant and total huntingtin expression in Huntington’s disease murine models
- (2020) Valentina Fodale et al. Scientific Reports
- Huntingtin Lowering Strategies for Disease Modification in Huntington’s Disease
- (2019) Sarah J. Tabrizi et al. NEURON
- Fluid and imaging biomarkers for Huntington's disease
- (2019) Paul Zeun et al. MOLECULAR AND CELLULAR NEUROSCIENCE
- A protein quality control pathway regulated by linear ubiquitination
- (2019) Eva M van Well et al. EMBO JOURNAL
- Targeting Huntingtin Expression in Patients with Huntington’s Disease
- (2019) Sarah J. Tabrizi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Impairment and Restoration of Homeostatic Plasticity in Cultured Cortical Neurons From a Mouse Model of Huntington Disease
- (2019) Amy I. Smith-Dijak et al. Frontiers in Cellular Neuroscience
- Mutant huntingtin enhances activation of dendritic Kv4 K+ channels in striatal spiny projection neurons
- (2019) Luis Carrillo-Reid et al. eLife
- Allele-selective transcriptional repression of mutant HTT for the treatment of Huntington’s disease
- (2019) Bryan Zeitler et al. NATURE MEDICINE
- Gene Therapy
- (2019) Katherine A. High et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lowering Mutant Huntingtin Using Tricyclo-DNA Antisense Oligonucleotides As a Therapeutic Approach for Huntington's Disease
- (2019) Marine Imbert et al. Nucleic Acid Therapeutics
- CAG Repeat Not Polyglutamine Length Determines Timing of Huntington’s Disease Onset
- (2019) Jong-Min Lee et al. CELL
- A divalent siRNA chemical scaffold for potent and sustained modulation of gene expression throughout the central nervous system
- (2019) Julia F. Alterman et al. NATURE BIOTECHNOLOGY
- Pridopidine protects neurons from mutant-huntingtin toxicity via the sigma-1 receptor
- (2019) Chelsy R. Eddings et al. NEUROBIOLOGY OF DISEASE
- Suppression of Mutant Protein Expression in SCA3 and SCA1 Mice Using a CAG Repeat-Targeting Antisense Oligonucleotide
- (2019) Eleni Kourkouta et al. Molecular Therapy-Nucleic Acids
- Patient-Customized Oligonucleotide Therapy for a Rare Genetic Disease
- (2019) Jinkuk Kim et al. NEW ENGLAND JOURNAL OF MEDICINE
- Design of Bivalent Nucleic Acid Ligands for Recognition of RNA-Repeated Expansion Associated with Huntington’s Disease
- (2018) Shivaji A. Thadke et al. BIOCHEMISTRY
- Translation of MicroRNA-Based Huntingtin-Lowering Therapies from Preclinical Studies to the Clinic
- (2018) Jana Miniarikova et al. MOLECULAR THERAPY
- AAV5-miHTT Gene Therapy Demonstrates Broad Distribution and Strong Human Mutant Huntingtin Lowering in a Huntington’s Disease Minipig Model
- (2018) Melvin M. Evers et al. MOLECULAR THERAPY
- Evaluation of mutant huntingtin and neurofilament proteins as potential markers in Huntington’s disease
- (2018) Lauren M. Byrne et al. Science Translational Medicine
- Huntingtin suppression restores cognitive function in a mouse model of Huntington’s disease
- (2018) Amber L. Southwell et al. Science Translational Medicine
- Operative Complications with and without Image Guidance: A Systematic Review and Meta-Analysis of the Ommaya Reservoir Literature
- (2018) Jonathan C. Lau et al. World Neurosurgery
- Longitudinal diffusion changes in prodromal and early HD: Evidence of white-matter tract deterioration
- (2017) Joseph J. Shaffer et al. HUMAN BRAIN MAPPING
- Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study
- (2017) Davina J Hensman Moss et al. LANCET NEUROLOGY
- Therapies targeting DNA and RNA in Huntington's disease
- (2017) Edward J Wild et al. LANCET NEUROLOGY
- Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington's disease: a retrospective cohort analysis
- (2017) Lauren M Byrne et al. LANCET NEUROLOGY
- CRISPR/Cas9 Editing of the Mutant Huntingtin Allele In Vitro and In Vivo
- (2017) Alex Mas Monteys et al. MOLECULAR THERAPY
- Neurotoxic reactive astrocytes are induced by activated microglia
- (2017) Shane A. Liddelow et al. NATURE
- The expanded CAG repeat in the huntingtin gene as target for therapeutic RNA modulation throughout the HD mouse brain
- (2017) Nicole A. Datson et al. PLoS One
- The pathogenic exon 1 HTT protein is produced by incomplete splicing in Huntington’s disease patients
- (2017) Andreas Neueder et al. Scientific Reports
- DNA repair pathways underlie a common genetic mechanism modulating onset in polyglutamine diseases
- (2016) Conceição Bettencourt et al. ANNALS OF NEUROLOGY
- A novel neurodevelopmental disorder associated with compound heterozygous variants in the huntingtin gene
- (2016) Lance H Rodan et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- Identification of novel genetic causes of Rett syndrome-likephenotypes
- (2016) Fátima Lopes et al. JOURNAL OF MEDICAL GENETICS
- Integrated genomics and proteomics define huntingtin CAG length–dependent networks in mice
- (2016) Peter Langfelder et al. NATURE NEUROSCIENCE
- Two different phenomena in basic motor speech performance in premanifest Huntington disease
- (2016) Sabine Skodda et al. NEUROLOGY
- The Biology of Huntingtin
- (2016) Frédéric Saudou et al. NEURON
- Ablation of huntingtin in adult neurons is nondeleterious but its depletion in young mice causes acute pancreatitis
- (2016) Guohao Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Human glia can both induce and rescue aspects of disease phenotype in Huntington disease
- (2016) Abdellatif Benraiss et al. Nature Communications
- Precision Modulation of Neurodegenerative Disease-Related Gene Expression in Human iPSC-Derived Neurons
- (2016) Sabrina Mahalia Heman-Ackah et al. Scientific Reports
- A SNP in the HTT promoter alters NF-κB binding and is a bidirectional genetic modifier of Huntington disease
- (2015) Kristina Bečanović et al. NATURE NEUROSCIENCE
- Increased central microglial activation associated with peripheral cytokine levels in premanifest Huntington's disease gene carriers
- (2015) Marios Politis et al. NEUROBIOLOGY OF DISEASE
- Hydrophobically Modified siRNAs Silence Huntingtin mRNA in Primary Neurons and Mouse Brain
- (2015) Julia F Alterman et al. Molecular Therapy-Nucleic Acids
- Insights into gait disorders: Walking variability using phase plot analysis, Huntington's disease
- (2014) Johnny Collett et al. GAIT & POSTURE
- Neuronal targets for reducing mutant huntingtin expression to ameliorate disease in a mouse model of Huntington's disease
- (2014) Nan Wang et al. NATURE MEDICINE
- YKL-40 in cerebrospinal fluid in Huntington's disease – A role in pathology or a nonspecific response to inflammation?
- (2014) Tua Vinther-Jensen et al. PARKINSONISM & RELATED DISORDERS
- Allele-Specific Suppression of Mutant Huntingtin Using Antisense Oligonucleotides: Providing a Therapeutic Option for All Huntington Disease Patients
- (2014) Niels H. Skotte et al. PLoS One
- Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data
- (2013) Sarah J Tabrizi et al. LANCET NEUROLOGY
- Six-month partial suppression of Huntingtin is well tolerated in the adult rhesus striatum
- (2012) Richard Grondin et al. BRAIN
- 18F-FDG PET uptake in the pre-Huntington disease caudate affects the time-to-onset independently of CAG expansion size
- (2012) Andrea Ciarmiello et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Sustained Therapeutic Reversal of Huntington's Disease by Transient Repression of Huntingtin Synthesis
- (2012) Holly B. Kordasiewicz et al. NEURON
- Widespread suppression of huntingtin with convection-enhanced delivery of siRNA
- (2011) David K. Stiles et al. EXPERIMENTAL NEUROLOGY
- Neurosurgical convection-enhanced delivery of treatments for Parkinson’s disease
- (2011) Miu Fei Lam et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data
- (2011) Sarah J Tabrizi et al. LANCET NEUROLOGY
- The Discovery of Zinc Fingers and Their Applications in Gene Regulation and Genome Manipulation
- (2010) Aaron Klug Annual Review of Biochemistry
- Microglial activation in regions related to cognitive function predicts disease onset in Huntington's disease: A multimodal imaging study
- (2010) Marios Politis et al. HUMAN BRAIN MAPPING
- Sustained effects of nonallele-specificHuntingtinsilencing
- (2009) Valérie Drouet et al. ANNALS OF NEUROLOGY
- Five siRNAs Targeting Three SNPs May Provide Therapy for Three-Quarters of Huntington's Disease Patients
- (2009) Edith L. Pfister et al. CURRENT BIOLOGY
- A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's disease
- (2008) Maria Björkqvist et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Artificial miRNAs mitigate shRNA-mediated toxicity in the brain: Implications for the therapeutic development of RNAi
- (2008) J. L. McBride et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Detection of Huntington's disease decades before diagnosis: the Predict-HD study
- (2007) J S Paulsen et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search